Nexus Energy Services Inc (OTCMKTS: IBGR) soon to be renamed Dryworld is making a steady run up the charts in recent trading on growing volume. The stock got a boost on Monday after the Company tweeted, they will be releasing big news tomorrow. Dryworld is followed by a significant number of athletes on Facebook and some fairly well-known social media influencers. The stock is getting noticed after reversing off $0.0521 lows earlier this year and has been moving steadily northbound since.
Dryworld is is opening its flagship store in Edmonton, Alberta at the new state of the art A1 Athletic Facility estimated to open in November of 2022. The A1 Athletic Facility will be Canadas largest indoor, dual sports dome providing every tool necessary to optimize athletes’ performance in Soccer, Football and other sports. A1 has a mission to open three locations in a few short years, with DRYWORLD securing the right to open flagship stores in all locations opened for the next ten years. The Company also just launched its partnership with Modell’s Sporting Goods–the longest operating sports retailer in the USA. The retailer has released Dryworld’s CoreD and HauteD product lines, as well as the brand’s flagship product DRYFEET, through their e-commerce store here.
Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!
Nexus Energy Services Inc (OTCMKTS: IBGR) operating as Dryworld is a premium performance sports brand offering innovative, superior quality apparel and gear for the athlete in all of us. The Company builds purpose-driven products that give all athletes the edge. Engineered by athletes, proven by science.
Dryworld began when two professional rugby players needed to keep their feet dry in the wet coastal climate. No existing product provided the solution, so they created their own: DRYFEET Performance Footwear. From this original innovation, DRYWORLD continues to revolutionize the market. Founded in Victoria, British Columbia, Canada in 2010, DRYWORLD is a performance athletic brand offering innovative, superior quality apparel and gear for the athlete in all of us. Innovative, purpose-driven products that give athletes the edge. The Company is in the process of changing its name and ticker symbol to DryWorld Brands Inc (OTCMKTS: DRYW)
Dryworld has produced several lines of clothing, such as HauteD, Aggression, BioSkyn Apparel and Barefuta. In 2016 the Company signed several deals with Brazilian football clubs, such as Atletico Mineiro and Fluminense and operates four manufacturing factories in Brazil.
IBGR is led by CEO Matt Weingart an ex Canadian rugby union player. His playing position was scrum-half. He was named in the Canada squad for the 2007 Rugby World Cup, although he did not make any appearances in the tournament. He though did make 7 international appearances for Canada between 2004 and 2007, before starting the sports clothing brand Dryworld. Brian McKenzie is a former international rep level rugby player. Originally from Scotland and now a Canadian citizen who has spent more than 20 years as an entrepreneur, holds a degree in engineering and has a broad range of expertise in finance, technology, real estate development and retail. The new co CEOs were joined by Barrett Evans as CFO and Director and Ron Minsky as dire
🔥 🔥 $IBGR 🔥🔥 Folks this is gonna be one for the record books imo!! If you haven’t taken the time to look at this company and setup with SS and what they are building you may be missing this opportunity. Don’t have to dig deep on this one. 💎🔥💎🔥💎🔥 https://t.co/TvtahVjsCj
To Find out the inside Scoop on IBGR Subscribe to Microcapdaily.com Right Now by entering your Email in the box below
Dryworld is opening its flagship store in Edmonton, Alberta at the new state of the art A1 Athletic Facility estimated to open in November of 2022. The A1 Athletic Facility will be Canadas largest indoor, dual sports dome providing every tool necessary to optimize athletes performance in Soccer, Football and other sports. The main floor of the clubhouse will include a full restaurant, Bar & Cafeteria in addition to an ultra-modern 2500 square foot gym designed for weight training and cardio conditioning. With a physiotherapy and/or rehabilitation service on site, athletes will have everything they need at A1 facility to take their game to the next level.
DRYWORLDs flagship store will be 425 sq ft of prime real estate at the main entrance of the clubhouse and gym in the large foyer that everyone who enters the building will have to walk past. A1 is projecting traffic of 1000 per day once fully booked, providing great visibility for the brand. As part of the deal, DRYWORLD will be the official technical partner of A1 Athletic Facility and will build a dynamic merchandise program designed to support athletes and those who support the athletes. A1 has a mission to open three locations in a few short years, with DRYWORLD securing the right to open flagship stores in all locations opened for the next ten years. The two performance focused brands are aligning with a likeminded vision to become the ultimate home for athletes.
The Company has released a proprietary line of team merchandise to represent the five teams and 40 athletes competing in Super League Triathlons Championship Series beginning next week. The series features the worlds fastest triathletes and kicked off in London on September 4th, with the Grand Finale in Neom on October 29th.
On September 13 IBGR announced launched its partnership with Modell’s Sporting Goods–the longest operating sports retailer in the USA. The retailer has released Dryworld’s CoreD and HauteD product lines, as well as the brand’s flagship product DRYFEET, through their e-commerce store here. In 2020, Modell’s was identified as one of the Top Ten Largest Sporting Goods Stores in the World, and currently carries legacy sports brands including Adidas, Nike, Asics, Fila, Champion, and Puma, as well as licensed merchandise for teams in the MLB, NFL, and NHL.
Co-CEO, Matt Weingart said: ‘‘Offering DRYWORLD products at one of the biggest sports merchants in North America unlocks the potential for our entire product line. Our partner teams and athletes can showcase their licensed merchandise to North American consumers, which is a very sought-after market globally. It’s very exciting for our company to have access to Modell’s customer base, we’re always working on getting more eyes on our products, and this partnership does just that.”
We’re always the first to tell you to push yourselves to your limits and beyond. But when it comes to back-to-back races, we have some tips to help you safely manage the intensity of your running season. 👟 Head to our blog for our tips! #Triathlon#Runnerspic.twitter.com/rp9IcwbnXy
Currently trading at a $19 million market valuation IBGR OS is 171,565,229 with 131,819,613 shares in the float. This is exciting story developing in small caps; the Company is is opening its flagship store in Edmonton, Alberta at the new state of the art A1 Athletic Facility estimated to open in November of 2022. The A1 Athletic Facility will be Canadas largest indoor, dual sports dome providing every tool necessary to optimize athletes performance in Soccer, Football and other sports. A1 has a mission to open three locations in a few short years, with DRYWORLD securing the right to open flagship stores in all locations opened for the next ten years. The Company also just launched its partnership with Modell’s Sporting Goods–the longest operating sports retailer in the USA. The retailer has released Dryworld’s CoreD and HauteD product lines, as well as the brand’s flagship product DRYFEET, through their e-commerce store here. IBGR has plenty of room for growth from current levels with the first real resistance at around $0.30 per share. The Company is waiting on the name change to Dryworld to take affect. Dryworld is followed by a significant number of athletes on Facebook and some fairly well known social media influencers. We will be updating on IBGR on a daily basis so make sure you are subscribed to microcapdaily.com so you know what is going on with IBGR.
Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!
Disclosure: we hold no position in IBGR either long or short and we have not been compensated for this article.
Aclarion, Inc. (NASDAQ: ACON) shares rocketed 157% Tuesday morning after their commercialization agreement with the London Clinic. The London Clinic is UK’s most renowned independent, private hospital, established 1932 with their Spine Clinic being the first specialist spinal unit based in England back in 1997.
“With a focus on providing the very best healthcare outcomes, The London Clinic is an ideal customer for Aclarion as the company works to deliver the Nociscan solution to physicians and patients around the world,” said John Sutcliffe MD, Neurosurgeon and Founder of London Spine Clinic. “The engagement with Aclarion will allow London Spine Clinic to continue offering the high-quality care our patients have come to expect. Patients need a careful assessment, diagnosis, and understanding of the different treatment options. Aclarion’s innovative Nociscan solution will enable us to objectively assess biomarkers associated with low back pain and enhance the precision of each diagnosis.”
$ACON Aclarion Announces New Engagement with The London Clinic and London Spine Clinic
Aclarion, Inc.’s Nociscan Technology is an innovative medical solution that aims to revolutionize the diagnosis of disc-related conditions. They leverage biomarkers and proprietary augmented intelligence algorithms to help physicians identify the location of chronic low back pain.
$ACON Watching for volume and run. Aclarion Announces New Engagement with The London Clinic and London Spine Clinic
What’s exciting is its advantages over the current standard of care. It offers a non-invasive approach, ensuring patient comfort and safety. Given it’s non-invasive, that also means 0 pain with 0 radiation (typically associated with traditional discography). The best part is it can seamlessly integrate into standard lumbar MRI protocols, making it a convenient and efficient option for healthcare providers.
To Discover the Inside Scoop on ACON, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.
Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!
The procedure takes approximately 25-45 minutes, thoroughly evaluating spinal discs without compromising accuracy. Additionally, Nociscan technology offers significant cost savings, with a list price of $1,450, making it an affordable alternative to traditional discograms. Overall, Aclarion, Inc.’s technological advances represent a significant push forward in disc-related diagnostic techniques, prioritizing patient well-being, convenience, and affordability.
They also recently completed a study that spanned two years and involved 78 patients at a single site. The success rate soared to an impressive 85% for patients whose treatment strategy aligned with the disks identified by Nociscan. This represented a remarkable 22% improvement over patients whose treatment strategy did not consider the insights provided by Nociscan.
Aclarion expressed confidence that the results of the trial demonstrate the potential of Nociscan to assist physicians in successfully treating DLBP. Dr. Matthew Gornet, orthopedic surgeon and lead author of the study, enthusiastically endorsed Nociscan, stating, “The two-year surgical outcomes of the clinical trial provide unequivocal evidence of its effectiveness, particularly with regards to the primary endpoint, the Oswestry Disability Index (ODI). I firmly believe that Nociscan has the potential to revolutionize the standard of care and accurately aid all physicians treating chronic low back pain.”
$ACON Watching for volume and run. Aclarion Announces New Engagement with The London Clinic and London Spine Clinic
It is worth noting that although Nociscan was performed on all patients in the study, it was not part of the surgical decision-making process, as highlighted by the company.
The commercial agreement between Aclarion, Inc. and the prestigious London Clinic signifies a significant milestone for both parties, carrying the potential for global recognition, revenue growth, and scalability. By integrating Aclarion’s innovative Nociscan Technology, the London Clinic demonstrates its commitment to delivering cutting-edge healthcare to optimize patient well-being and enhance clinical outcomes. Furthermore, the partnership’s success holds the potential for scaling Nociscan Technology to other institutions and markets, propelling Aclarion, Inc. to become a global leader in non-invasive medical technologies while driving substantial revenue growth.
We will update you on ACON when more details emerge, so make sure you are subscribed to Microcapdaily to know what’s happening in the markets!
Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!
Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.
Aemetis, Inc. (NASDAQ: AMTX) shares surged 105% this week. The renewable natural gas and renewable fuels company received approval from the U.S. EPA to generate renewable identification numbers (RINs) under the federal Renewable Fuel Standard. They have six dairy biogas digesters up and running, with a seventh one scheduled to start operating in June 2023.
Aemetis plans to generate multiple sources of revenue from its renewable natural gas. They will sell the gas to replace petroleum diesel in transportation, sell California Low Carbon Fuel Standard credits to fuel blenders who need to meet carbon reduction requirements in California, sell the RINs generated under the federal Renewable Fuel Standard, and benefit from production tax credits starting in 2025 under the Inflation Reduction Act.
They have completed constructing and operating six dairy digesters, a biogas pipeline spanning over 40 miles, a central facility to upgrade biogas to renewable natural gas, and a utility pipeline interconnection unit. The renewable natural gas is injected into the utility gas system and stored underground until Aemetis Biogas obtains carbon intensity (CI) pathway approvals from the California Air Resources Board (CARB) to sell credits under the California Low Carbon Fuel Standard.
$Amtx EPA approved kaboom another winner from rara koko private discord – we know the news and catalyst first stamp now 1025am 5/19/23 alert sent to subscribers cell phone all over the world -super fast super quick. pic.twitter.com/2RVHENSnqd
They have already completed 90 days of renewable natural gas production and data collection required for the CARB approval process. While the final pathway is under review by CARB, Aemetis can use a temporary CI pathway with a value of -150, allowing them to start generating revenue in the third quarter of 2023.
To Discover the Inside Scoop on AMTX, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.
Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!
Andy Foster, the president of Aemetis Biogas Inc., expressed excitement about the approval of Aemetis Biogas for generating D3 RINs, as it marks a significant milestone towards generating full product revenue. He emphasized that the company’s investments since 2019 have directly reduced greenhouse gas pollution, improved air quality in Central Valley communities, and created jobs. Aemetis is committed to expanding their network of dairy digesters and producing more carbon-negative renewable natural gas to replace petroleum diesel.
The dairy digesters, pipeline project, and biogas-to-RNG facility funding includes grants from the California Department of Food and Agriculture and the California Energy Commission. Aemetis also closed a $25 million long-term financing deal with Greater Commercial Lending last fall, supported by a loan guarantee from the USDA. This project financing has a low fixed interest rate for the first five years and spans over 20 years.
Aemetis has plans to file applications for an additional $100 million of loans from the USDA’s REAP loan program. These funds will support the engineering, permitting, and construction of 31 more dairies. Each loan application will be limited to a maximum of $25 million and carry a 20-year repayment term.
Where could Aemetis, Inc. (NASDAQ: AMTX) be in 5 years?
The company has an ambitious Five Year Plan to generate substantial revenue and reduce air and carbon pollution. The plan projects $2.0 billion in revenues, $496 million in net income, and $682 million in adjusted EBITDA by 2027, with strong compound annual growth rates. Aemetis aims to expand its operations by producing Renewable Natural Gas (RNG), Sustainable Aviation Fuel (SAF), Renewable Diesel fuel (RD), and other low-carbon products. The plan emphasizes the positive financial impact of the Inflation Reduction Act.
(told ya) Aemetis Setting Up For Short Squeeze $AMTX our 1-year price target is $17 to $22 https://t.co/kMxOgQYEk2
The plan highlights the financial benefits of the Inflation Reduction Act, which enables the transfer of tax credits and incentives related to production, projected to improve net income by $341 million in 2027.
The plan also focuses on revenue growth in all product lines, including expanding the dairy RNG business, constructing a renewable jet/diesel plant, implementing carbon sequestration, and improving energy efficiencies.
The company has already achieved significant milestones, such as completing biogas pipeline construction, upgrading facilities for biogas-to-RNG production, and progressing in carbon sequestration and renewable jet/diesel plant development. The company has also secured a biodiesel purchase agreement in India and made strides in constructing a solar microgrid and implementing energy-efficient measures.
We will update you on AMTX when more details emerge, so make sure you are subscribed to Microcapdaily to know what’s happening in the markets!
Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!
Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.
GSI Technology, Inc. (NASDAQ: GSIT) has witnessed a significant surge in its stock price, from $1.62 to $3.84, at the time of writing on Friday, May 12. This represents an impressive 137% increase; the volume has been off the hook. If you look at their historical chart, $GSIT had meager volume, sometimes as low as 300 shares traded in a day. If you do the math, that’s less than $500 worth of shares traded in a day – safe to say it was virtually illiquid.
So what happened, and what drove the stock to trade 50M shares with filings or news releases?
After an in-depth examination, GSI Technology, Inc. appears to have experienced a notable turning point in its market trajectory. The catalyst for this transformation was the company’s prominent feature on Fox News, triggering an exponential dissemination of information across various platforms. It is worth highlighting an intriguing phenomenon that tends to transpire in such circumstances: purchasing shares often induces a ripple effect, encouraging further buying activity.
With Fox News bringing the company into the spotlight and stimulating investor interest, a domino effect occurred among astute day traders who eagerly seized the opportunity to partake in this promising venture. Consequently, the trading volume for GSI Technology, Inc. skyrocketed to unprecedented levels, surpassing all previously recorded thresholds.
$GSIT GSIT +64% this am: Number one pick for AI on stew varney fox business moments ago. Analyst said if your broker recommends Invidia fire them this is the company that could be leader of the world and AI.
This surge in volume stands as a testament to the immense enthusiasm that enveloped the market as traders recognized the tremendous potential inherent in $GSIT. This collective enthusiasm resulted in an extraordinary demonstration of market engagement, reflecting a widespread acknowledgment of the company’s significance and the opportunities it presents.
This development showcases the power of influential media coverage and underscores the intriguing dynamics that can arise when investor sentiment aligns with a compelling market narrative.
To Discover the Inside Scoop on GSIT, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.
Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!
Founded in 1995, GSI Technology Inc. has established itself as a prominent provider of semiconductor memory solutions. The company is focused on introducing new products that capitalize on its core strengths, which include radiation-hardened memory products for extreme environments and Gemini, an advanced processing unit (APU) designed to enhance performance in various artificial intelligence (AI) applications. Headquartered in Sunnyvale, California, GSI Technology operates sales offices in the Americas, Europe, and Asia.
$GSIT been doing this a long time & always makes me laugh NO one wanted GSIT at $1.50 or CASH on hand but killing it at $3.20 $$$
GSI Technology is on the verge of reporting its earnings next week, and the company operates in the storage business, which supports the development of highly efficient AI chips. Traditionally, computing involves separate chips for storage and computation, necessitating frequent data exchange. This process incurs significant power consumption and presents scalability challenges.
To address these limitations, GSI Technology has developed a groundbreaking solution called In-memory processing. This innovation substantially reduces computation time from minutes to seconds, milliseconds, or even microseconds. Notably, it also significantly diminishes power consumption and overall cost of ownership. The key to this improvement lies in the massive parallel data processing offered by GSI’s technology, featuring two million-bit processors per chip compared to thousands found in standard graphic processing units (GPUs). Consequently, the system becomes more scalable, enabling efficient and accelerated AI processing.
By streamlining the computing process and integrating storage and computation on a single chip, GSI Technology aims to revolutionize AI processing. This approach offers notable benefits regarding power efficiency, computational speed, and scalability, making it an attractive solution for a wide range of AI applications.
$GSIT earnings May 16 after the market close. Low volume domestic semi conductor. My favorite sector. I have buys at 1.60 and 1.64
In conclusion, GSI Technology, Inc. is poised to deliver innovative semiconductor memory solutions emphasizing AI chip development. The company aims to reduce computation time, power consumption, and total ownership cost through its In-memory processing technology while significantly improving scalability. With its upcoming earnings report, investors and industry observers will closely watch the company’s progress in the storage business and AI chip development.
We will update you on GSIT when more details emerge, so make sure you are subscribed to Microcapdaily to know what’s happening with GSIT.
Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!
Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.